-- Biocon of India May Spin Off Syngene Unit Within Two Years, Chairman Says
-- B y   A d i   N a r a y a n   a n d   J a y   S h a n k a r
-- 2010-11-04T03:33:49Z
-- http://www.bloomberg.com/news/2010-11-04/biocon-may-spin-off-syngene-research-unit-by-may-2012-mazumdar-shaw-says.html
Biocon Ltd., Indiaâ€™s biggest
biotechnology company, may spin off its Syngene contract
research unit as early as May 2012, Chairman Kiran Mazumdar-Shaw
said.  Biocon, based in Bangalore, plans an initial public
offering of Syngene during the next 18 to 24 months and expects
to hire as many as 500 people in India by December 2011,
Mazumdar-Shaw said in an interview yesterday.  To contact the reporter on this story:
Adi Narayan in Mumbai at 
 anarayan8@bloomberg.net   To contact the editor responsible for this story:
Jason Gale at 
 j.gale@bloomberg.net  